Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.
<h4>Background</h4>The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the presen...
Enregistré dans:
Auteurs principaux: | Roeland Huijgen, Iris Kindt, Sjoerd B J Verhoeven, Eric J G Sijbrands, Maud N Vissers, John J P Kastelein, Barbara A Hutten |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aacec6727baa4906b11ca1389e4c5dd5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
par: Joe Kai, et autres
Publié: (2021) -
Nursing Research and Education: Goals Reached
par: María de los Ángeles Rodríguez Gázquez
Publié: (2016) -
Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
par: Chamberlin KW, et autres
Publié: (2015) -
Plant protein reduces serum cholesterol levels in hypercholesterolemia hamsters by modulating the compositions of gut microbiota and metabolites
par: Li-Tao Tong, et autres
Publié: (2021) -
Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
par: Elisenda Climent, et autres
Publié: (2017)